Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Articles

Low Blood Pressure in Down's Syndrome

A Link With Alzheimer's Disease?

Rhona A. Morrison, Alice McGrath, Gillian Davidson, Jehoiada J. Brown, Gordon D. Murray, Anthony F. Lever
https://doi.org/10.1161/01.HYP.28.4.569
Hypertension. 1996;28:569-575
Originally published October 1, 1996
Rhona A. Morrison
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alice McGrath
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gillian Davidson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jehoiada J. Brown
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon D. Murray
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony F. Lever
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Selected Abbreviations and Acronyms
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

Abstract

Low blood pressure is reported in Down's syndrome (DS). To assess this and determine whether low pressure results from the disease or from long-term residence in hospital, we measured blood pressure with a random-zero sphygmomanometer in three groups of patients: 52 DS inpatients, 62 DS outpatients, and 60 outpatients with other forms of mental handicap. Relative to normal reference populations, blood pressure was low in both DS inpatients (systolic, score −33 mm Hg, P<.0001) and DS outpatients (−25 mm Hg, P<.0001). It was normal in non-DS outpatients (−4.0 mm Hg, P=.3). Blood pressure rose normally with age in the non-DS group but not in the DS group. We conclude that blood pressure is low in DS and that this is a feature of the disease rather than of the protected environment in which patients live. A mechanism related to trisomy 21 is likely, and there may be a link with Alzheimer's disease (AD) because blood pressure is also low in Alzheimer's and a high proportion of DS patients develop this disease. If, as is likely, blood pressure is lowered in Alzheimer's by the neuropathy, the same neuropathy developing early in DS may also reduce blood pressure.

  • hypotension
  • Down's syndrome
  • Alzheimer's disease
  • amyloid beta-protein
  • sympathetic nervous system

There are reports of low BP in DS, lower than in other forms of mental handicap and lower than in a normal population.1 2 However, the patients in these studies were long-term hospital residents, which may itself lower BP. Psychiatric inpatients also have low BP that is not related to treatment or psychiatric diagnosis; it is not present on admission but appears gradually as a failure of BP to rise normally with age.3 Such failure is seen in patients with physical disease living in the long term in a hospital,4 in healthy women residing long-term in a nunnery,5 and in entire populations living in isolated circumstances.6

A study of BP in DS needs to be controlled for these effects. Such study is necessary because if low BP is a feature of DS, an inquiry on mechanisms will turn on the relation of arterial pressure and trisomy 21. There may be a link here with AD, a condition that often develops in DS7 and in some familial forms maps to chromosome 218 and also has low BP (see “Discussion”). Our plan was to determine whether BP is low in DS patients living in and out of the hospital and whether BP is low or normal in outpatients with other forms of mental handicap of similar degree.

Methods

Patients

BP was measured in 174 patients with mental handicap who were divided into three groups. Group A was 52 patients with DS (36 male), all long-term residents either in The Royal Scottish National Hospital for the Mentally Handicapped or in Merchiston Hospital. Group B included 62 patients with DS (35 male) living at home or in a hostel attending by day one of five ATCs where BP was measured. Group C was 60 patients (39 male) who did not have DS but had a mental handicap of similar degree; all lived at home or in a hostel attending by day the same ATCs as the patients in group B. The study began in 1983 with BP measured by one of the researchers (R.M.) in groups A and B; later measurements were by the same researcher and a second one (A.McG.). For assessment of changes with age, measurements were repeated 10 years later (by R.M.) in 22 group B patients. Clinical features of DS were present in every patient; chromosome analysis in 19 showed trisomy 21 in 18 patients and Robertsonian translocation in 1 [(46,XX,−14)+t(14q21q)]. Medical staff examined all patients; 1 with congenital heart disease was excluded. Three others with precordial systolic murmurs considered insignificant and pressures of 108/69, 108/58, and 109/77 mm Hg were included. There were no other exclusions. The study was a near-complete sample of all available cases.

Reference Populations

Comparison was made with four reference populations: (1) Subjects attending outpatient clinics of a London hospital; a conventional sphygmomanometer was used for BP measurement, and phase IV diastolic BP was recorded9 ; (2) the Renfrew/Paisley survey,10 11 a population study with diastolic BP (phase V) measured by a London School of Hygiene sphygmomanometer in Renfrew and a Hawksley RZS in Paisley; (3) Glasgow cohort studies, with measurements by RZS (phase V diastolic) in cohorts aged 15, 35, and 55 years12 ; and (4) the Scottish Heart Health Study,13 with an RZS used and phase V diastolic recorded. Because agreement between populations was reasonable (Fig 1⇓), the method of Hamilton et al14 was used for calculation of the deviation of a patient's BP from the reference populations (Table 1⇓). From this, a systolic BP score was derived14 that was adjusted for sex and corrected for age (to 60 years). The two hospitals, five ATCs, and two of the reference populations11 12 were within 20 miles of central Glasgow.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Systolic and diastolic BPs in men (left) and women (right) of four reference populations: that of Hamilton et al,9 the Scottish Health Heart Study (SHHS),13 Glasgow Cohort Studies,12 and Renfrew/Paisley Study.10 11

View this table:
  • View inline
  • View popup
Table 1.

Blood Pressure in the Study Groups and Deviations From Reference Populations

Blood Pressure

Two researchers (R.M. and A.McG.) were trained to use the RZS by research sisters of the Medical Research Council (MRC) Blood Pressure Unit, one of whom (G.D.) also trained nurses measuring pressure in the cohort studies.12 Measurements by the two researchers agreed well when simultaneous recordings were made in the right and left arms of a series of patients.

All patients in this study had three BP measurements (phase V diastolic BP recorded), one on each of three occasions up to 2 weeks apart; the mean of these was used in analysis. Measurements were in the morning, with subjects seated, after 5 minutes of relaxation, and with the sphygmomanometer at heart level. For group A, measurements were made in the ward or occupational therapy department, and for groups B and C, in an ATC. The RZS used was serviced regularly. BP was also measured by ambulatory monitor (model 90207, SpaceLabs Inc) programmed to reduce pressure in steps of 4 mm Hg and to record hourly. Height and weight were measured in 57 DS patients (22 female).

Consent was obtained from patients, from the Superintendent for studies at The Royal Scottish National Hospital, from the Ethics Committee of The Royal Alexandra Hospital for studies at Merchiston Hospital, and from the Social Work Department for studies in ATCs. Consent was also obtained from next of kin or guardian or, in their absence, from the consultant in charge (inpatients) or from staff at the ATC. The form of the study was explained to all patients. Fewer than 20 patients refused, and none that participated experienced any ill effects.

Results

Reference Populations

BP increased with age in our four reference populations (Fig 1⇑). The regression for phase IV diastolic BP in the Hamilton data9 was not higher than that for phase V diastolic BP in the three other populations (Fig 1⇑); differences between populations were more marked for systolic BP in women (Fig 1⇑).

Group A: DS Inpatients

BP was low in long-term DS inpatients. Low systolic and diastolic BPs relative to reference populations were seen in both men and women (Figs 2 and 3⇓⇓, Table 1⇑). Systolic score was −32.8 mm Hg, significantly lower (P<.0001) by this amount than BP in the reference population after adjustment for age and sex (Table 2⇓).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Relation of age with systolic BP (SBP) and diastolic BP (DBP) in men with DS living in and out of the hospital and with other forms of mental handicap (non-DS) living outside of the hospital. H indicates the reference population of Hamilton et al9 for men (see Fig 1⇑).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Relation of age with systolic BP (SBP) and diastolic BP (DBP) in women with DS living in and out of the hospital and with other forms of mental handicap (non-DS) living outside of the hospital. H indicates the reference population of Hamilton et al9 for women (see Fig 1⇑).

View this table:
  • View inline
  • View popup
Table 2.

Systolic Blood Pressure Scores

Group B: DS Outpatients

BP was also low in DS patients living outside the hospital (Figs 2 and 3⇑⇑, Table 1⇑); systolic score was −25.4 mm Hg, again a highly significant (P<.0001) downward deviation from the reference population (Table 2⇑). Scores were not significantly different in DS inpatients and outpatients (Table⇑s 1 and 2). The patient with translocation (see “Methods”) had a pressure of 97/47 mm Hg.

Ambulatory monitoring in five DS patients confirmed the low BP (daytime average, 105/63 mm Hg), which was similar to that recorded by the RZS (101/62 mm Hg) (Table 3⇓, Fig 4⇓). In four of these patients, BP decreased at night, but in the patient whose BP by day was lowest, BP did not decrease at night (Fig 4⇓).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Records of ambulatory BP from five DS inpatients. Mean daytime and nighttime BP values and comparison with daytime recording of BP in the same patients by RZS are shown in Table 3⇓.

View this table:
  • View inline
  • View popup
Table 3.

Ambulatory Blood Pressure Monitoring in Five Patients With Down's Syndrome

Data in Figs 2 and 3⇑⇑ suggest a failure of BP to rise with age in DS patients; regressions were flatter than those of reference populations. This was confirmed by repeat measurements after 10 years in 22 DS patients. In these individuals, BP did not increase with time; the trend was for a decrease (Fig 5⇓). The downward deviation from control subjects increased significantly with time (P=.004, Fig 5⇓).

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Changes of systolic and diastolic BP over 10 years in 22 subjects. Mean values (triangles) for systolic and diastolic BP in men and women were lower on the second occasion but not significantly so (paired t for systolic in men, 1.896; P=.08). Systolic BP score decreased significantly: +2.27 mm Hg at the first measurement and −17.73 mm Hg at the second (paired t, 3.24; P=.004).

Group C: Other Forms of Mental Handicap

A different picture emerged in patients with other forms of mental handicap living in the same semiprotected environment as DS outpatients (group B): Systolic and diastolic BPs and systolic BP score were higher than in DS patients and insignificantly different from values in the reference populations (Figs 2 and 3⇑⇑, Tables 1 and 2⇑⇑). Thus, in this semiprotected environment outside the hospital, DS patients showed subnormal pressure and no rise with age, and non-DS patients showed normal pressure and a normal rise with age.

High BP was more common in the non-DS patients, 5 of whom were diagnosed as hypertensive and were receiving hypotensive drugs. No DS patient was so diagnosed or treated. Of 60 non-DS patients, 19 had diastolic BP greater than 90 mm Hg; only 1 of 114 DS patients had a level this high (χ2=36.6, P<.001). One female DS patient with BP of 103/65 mm Hg was taking a diuretic for other reasons; 2 others with DS were taking drugs that might lower BP (lofepramine in one [BP 77/41 mm Hg] and thioridazine in the other [BP 92/52 mm Hg]). Values in 3 DS women taking oral contraceptives were 103/81, 109/75, and 83/53 mm Hg.

Relation of BP to Height and Weight

In DS men, weight related positively and significantly to systolic BP (r=.50, P<.01) and systolic score (r=.48, P<.01). Body mass index (weight [kilograms] divided by height [meters squared]) also related to systolic and diastolic BPs (r=.62 and r=.43, respectively; both P<.01). Height was not significantly related to BP or BP score. In women, numbers were smaller and correlations insignificant.

Discussion

Methodology and Artifacts

DS has high mortality, particularly in early life.15 Is BP low in DS because those individuals with highest pressure have the highest mortality, a selective effect favoring survival of patients with low pressure? Against this is the large reduction of mortality seen in adult DS patients in recent years15 and the rarity in DS of CHD,1 15 the most common cause of death in patients with highest pressure. Also, among DS patients who did survive, BP remained low and did not rise with age (Fig 5⇑).

BP was measured by the Hawksley RZS, which is less susceptible to observer bias than the conventional sphygmomanometer used in previous studies of DS.1 2 Although the RZS does underestimate BP,16 it does so by only between 1.0 and 3.8 mm Hg systolic.16 17 18 19 This is insufficient to explain the subnormality seen here in DS patients (Table 1⇑). Also, BP is not underestimated when all measurements are by the RZS, for example, when comparing DS and non-DS groups (Figs 2 and 3⇑⇑, Table 1⇑). Low BP was confirmed in DS patients with the use of ambulatory monitoring; ambulatory values were lower than BP values in a general population measured by the same technique.20

Is BP Lowered in DS by an Environmental Factor?

Low BP in DS patients living inside and outside the hospital suggests that a hospital environmental factor does not entirely explain this phenomenon in DS. Lower BP in DS than in non-DS patients, both living outside the hospital, further suggests that BP is not lowered in DS by an environmental factor acting outside the hospital. Together, data from our study and others2 3 4 suggest that although there are factors in the hospital environment that contribute to lower BP, these are not responsible for the low BP in DS. A mechanism related to trisomy 21 is more likely.

The cheerful disposition of DS patients, a well-recognized feature of trisomy 21, might contribute to lowering of BP, but we did not design our study to assess this. The similarity of BP values in the presence and absence of doctors (Table 3⇑) also raises the possibility of a diminished white coat pressor response (see Reference 21) in DS patients, but our observations here were in five patients only.

Cystathionine β-Synthase

Links are suggested in DS among low BP, low risk of CHD,1 and protection against CHD from increased cystathionine β-synthase.22 The gene for this enzyme is on chromosome 21, and increased enzyme levels have been reported22 but not by all researchers.23 The evidence linking arterial pressure with CHD and CHD with the enzyme is clear.24 The link between the enzyme and arterial pressure is less clear.

BP and Growth in Children

Mechanisms controlling growth in children may also influence arterial pressure later in adult life.25 Growth, particularly the increase in height, is retarded in DS children.26 Is BP lowered in DS adults by underactivity of a growth-promoting mechanism in childhood? Our data are not helpful here. Although arterial pressure was significantly related to weight and body mass index in DS patients, it was not significantly related to height. This correlation pattern is seen in a general population27 ; it is not special to DS.

Neuropathology of DS: A Link With AD?

It is more likely that BP is lowered in DS by the widespread neuropathy. This is apparent in fetal life and then later as a failure of growth and maturation in the brain, with loss of neurones28 29 and dendrites.30 Cholinergic nerves are particularly vulnerable.31 Reports of postural hypotension32 and the failure of heart rate and BP to rise normally with maximum exercise33 34 suggest autonomic failure in DS. Maximum exercise capacity is lower in patients with DS than in individuals with other forms of mental handicap.34

By 35 years of age, most DS patients additionally have pathological features of AD: atrophy of neurones, β-amyloid plaques and deposits, neurofibrillary tangles, and β-amyloid cerebral angiopathy.7 8 35 Although most of these lesions also occur in elderly nondemented control subjects, they are fewer in number at a given age.7 36 By the age of 45 years, almost half of DS patients have clinical manifestations of AD as well.15 These observations are relevant because low BP is also seen in AD (discussed below), and 46% of our DS patients were 35 years old or older.

AD and DS are also linked at the molecular level (see References 7, 8, 37, and 38). Some familial forms of AD map to chromosome 21, and closely related on the proximal part of its long arm is the gene coding for β-amyloid precursor protein. This and its product β-A4 protein are favored candidates for AD.7 37 38 Supporting this is the recent demonstration of AD neuropathy in transgenic mice bearing the mutant β-amyloid precursor protein gene of one of the familial forms of AD.39

Low BP in AD

BP is low in AD, lower than in elderly control subjects and lower than in other forms of dementia.40 41 42 43 Burke and colleagues42 reported serial measurements of BP in three patients with AD. In each, BP was falling at or before the time of diagnosis, and in one, the fall was marked. Although there is a resemblance here with serial measurements in DS (Fig 5⇑), we cannot say whether a decrease of BP in DS is an early manifestation of AD. There is considerable difficulty in diagnosing early AD in patients who already have DS and mental handicap.

Postural hypotension is also reported in AD and has sympathetic and cholinergic components.43 44 Neuropathological findings also point to cholinergic deficits in AD and DS.31 42 45 Another feature shared by the two diseases is the rarity of hypertension (present study and References 40 and 41) and of atherosclerosis and CHD.1 15 40 46 47

Nerve centers and neurotransmitters regulating arterial pressure (see Reference 48) are often affected in AD.42 A deficiency of glutamate or norepinephrine could impair synaptic transmission; a deficiency of γ-aminobutyric acid could enhance it.48 Lesions of AD are present in the C1 adrenergic system,42 a control center for the BP baroreflex.42 48 Other centers and transmitters affected are glutamate and norepinephrine in the hippocampus,38 49 γ-aminobutyric acid in the amygdala,38 acetylcholine in the caudate nucleus,31 and norepinephrine in the locus coeruleus.38 Although there is clear potential here for a net hypotensive effect, the balance of mechanisms producing it is not clear. Lesions of the C1 system are very likely to be involved.42

Could BP be lowered in DS by the same neuropathy? The AD neuropathy developing in DS is said to be indistinguishable from that developing in the common sporadic form of AD (see Reference 35). The important and probably primary β-amyloid lesion is already visible by a specific histochemical technique in DS children. Thereafter, the density of lesions increases to reach a plateau after 50 years of age.35 Interestingly, at this stage, the lesions are more conspicuous in DS than in sporadic AD.35 β-Amyloid precursor protein is also measurable in plasma, and here too the concentration is higher in DS than in AD.50 If neuropathy lowers BP in AD, the same neuropathy developing in DS, certainly earlier and probably to a greater degree, is likely to contribute to BP lowering here as well.

Regional Cerebral Perfusion Is Reduced in AD

A reduced regional cerebral perfusion is well recognized in AD. The technique usually used to measure it is single photon emission computed tomography.51 The reduction of perfusion is mainly in the temporoparietal cortex52 53 54 55 and hippocampus56 and matches in degree the deficit of cognition.53 54 The most widely favored interpretation (see References 42 and 52) is that neurone death reduces the oxygen requirement and blood flow falls to match demand. Normally, regional blood flow in the brain is closely coupled to local metabolic demand.57 In AD, cell death is seen to be produced by a mechanism other than underperfusion, for example, by a toxic effect of β-amyloid (see discussion above and Reference 58). Several workers have considered an additional process in which underperfusion contributes to neuropathology: an ischemic mechanism perhaps.59 60 For example, Englund and colleagues60 suggest that ischemia aggravated by low BP produces in white matter selective incomplete infarction, axon death, and demyelination. This is a different and less-specific neuropathy than the gray matter lesions of AD, but it often occurs in AD with the gray matter lesions.60 61

Low BP could contribute to underperfusion only if pressure fell below the level at which cerebral autoregulation is able to maintain flow by vasodilatation (see References 57 and 62). However, in this event, underperfusion would be generalized, and studies of cerebral perfusion52 53 54 55 56 show that this is not the case: The underperfusion in AD is localized mainly to temporoparietal and hippocampal regions. For low BP to contribute to underperfusion in these circumstances, local failure of autoregulation is needed as well. That this might be present in AD is suggested in one study52 showing a reduction of the vasodilator response to CO2 most marked in temporoparietal regions.

Thus, it is likely that neuropathy lowers BP in DS and AD and that the same β-amyloid neuropathy may lower BP in both disorders. A case has been made for underperfusion or low BP causing further (and different) neuropathy. More evidence is needed here.

In conclusion, BP is low in DS patients, equivalent at 60 years of age to a systolic BP 29 mm Hg lower than that in a general population. Long-term hospital residence, which can lower BP, is not responsible. More likely, a neuropathy affects BP control centers. BP is also low in AD, a condition frequently developing in DS. We suspect that the mechanism lowering BP is the same in both conditions.

Selected Abbreviations and Acronyms

AD=Alzheimer's disease
ATC=Adult Training Centre
BP=blood pressure
CHD=coronary heart disease
DS=Down's syndrome
RZS=random-zero sphygmomanometer

Acknowledgments

Prof A.F. Lever is supported by grants from the Medical Research Council (MRC G94/24751) and the British Heart Foundation (PG 94/117). We thank Ann Matheson for secretarial help and Randa Reid for the literature search.

  • Received January 19, 1996.
  • Revision received February 2, 1996.
  • Accepted April 2, 1996.

References

  1. ↵
    Murdoch JC, Rodger JC, Rao SS, Fletcher CD, Dunnigan MG. Down's syndrome: an atheroma-free model? Br Med J. 1977;2:226-228.
  2. ↵
    Richards BW, Enver F. Blood pressure in Down's syndrome. J Ment Defic Res. 1979;23:123-135.
    OpenUrlPubMed
  3. ↵
    Masterton G, Main CJ, Lever AF, Lever RS. Low blood pressure in psychiatric inpatients. Br Heart J. 1981;45:442-446.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Hatama S, Tsuchihashi T, Shida K, Kawashima H, Fujii K, Onoyama K, Futishima M. Lack of blood pressure increase with age in long-term hospitalised patients with the sequelae of acute carbon monoxide poisoning. J Hum Hypertens. 1993;7:19-23.
    OpenUrlPubMed
  5. ↵
    Timio M, Verdecchia P, Venanzi S, Gentili S, Ronconi M, Francucci B, Montanari M, Bicisao E. Age and blood pressure changes: a 20-year follow-up study in nuns in a secluded order. Hypertension. 1988;12:457-461.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Poulter NR, Khaw KT, Hopwood BEC, Mugambi M, Peart WS, Rose G, Sever PS. The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. Br Med J. 1990;300:967-972.
  7. ↵
    Wisniewski HM, Silverman W, Wegiel J. Ageing, Alzheimer disease and mental retardation. J Intellect Disabil Res. 1994;38:233-239.
  8. ↵
    Alzheimer's disease, Down's syndrome and chromosome 21. Lancet. 1987;1:1011-1012. Editorial.
    OpenUrlCrossRefPubMed
  9. ↵
    Hamilton M, Pickering GW, Roberts JAF, Sowry GSC. The aetiology of essential hypertension, I: the arterial pressure in the general population. Clin Sci. 1954a;13:11-35.
  10. ↵
    Hawthorne VM, Greeves DA, Beevers DG. Blood pressure in a Scottish town. Br Med J. 1974;2:600-603.
  11. ↵
    Isles CG, Hole DJ, Hawthorne VM, Lever AF. Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet. 1992;339:702-706.
    OpenUrlCrossRefPubMed
  12. ↵
    West P, Ford G, Hunt K, Macintyre S, Ecob R. How sick is the West of Scotland? Age-specific comparisons with national datasets on a range of health measures. Scot Med J. 1994;39:101-109.
  13. ↵
    Smith WCS, Tunstall-Pedoe H, Crombie IK, Tavendale R. Concomitants of excess coronary deaths: major risk factor and lifestyle findings from 10,359 men and women in the Scottish Heart Health Study. Scot Med J. 1989;34:550-555.
  14. ↵
    Hamilton M, Pickering GW, Roberts JAF, Sowry GS. The aetiology of essential hypertension, II: scores for arterial blood pressure adjusted for differences in age and sex. Clin Sci. 1954b;13:37-49.
  15. ↵
    Thase ME. Longevity and mortality in Down's syndrome. J Ment Defic Res. 1982;26:177-192.
    OpenUrlPubMed
  16. ↵
    O'Brien E, Mee F, Atkins N, O'Malley K. Inaccuracy of the Hawksley random zero sphygmomanometer. Lancet. 1990;336:1465-1468.
    OpenUrlCrossRefPubMed
  17. ↵
    Mackie A, Whincup P, McKinnon M. Does the Hawksley random zero sphygmomanometer underestimate blood pressure, and by how much? J Hum Hypertens. 1995;9:337-343.
    OpenUrlPubMed
  18. ↵
    Kinirons MT, Maskrey VL, Lawson M, Swift CG, Jackson SHD. Hawksley random zero sphygmomanometer versus standard sphygmomanometer: an investigation of mechanisms. J Hum Hypertens. 1995;9:571-573.
    OpenUrlPubMed
  19. ↵
    Kronmal RA, Rutan GH, Manolia TA, Borhani NO. Properties of the random zero sphygmomanometer. Hypertension. 1993;21:632-637.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    O'Brien E, Murphy J, Tyndall A, Atkins N, Mee F, McCarthy G, Staessen J, Cox J, O'Malley K. Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. J Hypertens. 1991;9:355-360.
    OpenUrlCrossRefPubMed
  21. Pickering TG. White coat hypertension. In: Laragh JA, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. 2nd ed. New York, NY: Raven Press Publishers; 1994:1913-1928.
  22. ↵
    Chadefaux B, Ceballos I, Hamet M, Coude M, Poissonnier M, Kamoun P, Allard D. Is absence of atheroma in Down's syndrome due to decreased homocysteine levels? Lancet. 1988;2:741.
    OpenUrl
  23. ↵
    Brattstrom L, Israelsson B, Tengborn L, Hultberg B. Homocysteine, factor VII and antithrombin III in subjects with different gene dosage for cystathionine beta-synthase. J Inherit Metab Dis. 1989;12:475-482.
    OpenUrlCrossRefPubMed
  24. ↵
    Dudman NPB, Wilcken DEL, Wang J, Lynch JF, Macey D, Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease: its occurrence, cofactor therapy and enzymology. Arterioscler Thromb. 1993;13:1253-1260.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Lever AF, Harrap SB. Essential hypertension: a disorder of growth with origins in childhood? J Hypertens. 1992;10:101-120.
    OpenUrlCrossRefPubMed
  26. ↵
    Cronk C, Crocker AC, Pueschel SM, Shea AM, Zackai E, Pickens G, Reed RB. Growth charts for children with Down's syndrome: 1 month to 18 years of age. Pediatrics. 1988;81:102-110.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Miall WE, Bell RA, Lovell HG. Relation between change in blood pressure and weight. Br J Prev Soc Med. 1968;22:73-80.
    OpenUrlPubMed
  28. ↵
    Wisniewski KE, Laura-Kamionowska M, Wisniewski HM. Evidence of arrest of neurogenesis and synaptogenesis in brains of patients with Down's syndrome. N Engl J Med. 1984;311:1187-1188.
    OpenUrlPubMed
  29. ↵
    Wisniewski KE. Down's syndrome children often have brain with maturation delay, retardation of growth and cortical dysgenesis. Am J Genet Suppl. 1990;7:274-281.
  30. ↵
    Takashima S, Iida K, Mito T, Arima M. Dendritic and histochemical development and ageing in patients with Down's syndrome. J Intellect Disabil Res. 1994;38:265-273.
  31. ↵
    Yates CM, Simpson J, Maloney AFJ, Gordon A, Reid AH. Alzheimer-like cholinergic deficiency in Down's syndrome. Lancet. 1980;2:979.
    OpenUrlPubMed
  32. ↵
    Pavey RJ. Pretreatment systolic orthostatic blood pressure depression in Down's syndrome. J Clin Psychopharmacol. 1989;9:146-147. Letter.
    OpenUrlPubMed
  33. ↵
    Eberhard Y, Eterradossi J, Rapacchi B. Physical aptitude to exertion in children with Down's syndrome. J Ment Defic Res. 1989;33:167-174.
  34. ↵
    Pitetti KH, Climstein M, Campbell KD, Barrett PJ, Jackson JA. The cardiovascular capacities of adults with Down's syndrome: a comparative study. Med Sci Sports Exerc. 1992;24:13-19.
    OpenUrlPubMed
  35. ↵
    Hyman BT, West HL, Rebec W, Lai F, Mann DMA. Neuropathological changes in Down's syndrome hippocampal formation. Arch Neurol. 1995;52:373-378.
    OpenUrlCrossRefPubMed
  36. ↵
    Roth M. The association of clinical and neurobiological findings and its bearing on the classification and aetiology of Alzheimer's disease. Br Med Bull. 1986;42:42-50.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Rossor MN. Catastrophe, chaos and Alzheimer's disease. J R Coll Physicians Lond. 1995;29:412-418.
    OpenUrlPubMed
  38. ↵
    Lantos PL, Cairns NJ. The neuropathology of Alzheimer's disease. Dementia. 1994;5:185-207.
  39. ↵
    Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnston-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 1995;373:523-527.
    OpenUrlCrossRefPubMed
  40. ↵
    Tresch DD, Folstein MF, Rabins PV, Hazzard WR. Prevalence and significance of cardiovascular disease and hypertension in elderly patients with dementia and depression. J Am Geriatr Soc. 1985;33:530-537.
    OpenUrlPubMed
  41. ↵
    Landin K, Blennow K, Wallin A, Gottfries C-G. Low blood pressure and blood glucose levels in Alzheimer's disease: evidence for a hypometabolic disorder? J Intern Med. 1993;233:357-363.
    OpenUrlPubMed
  42. ↵
    Burke WJ, Coronado PG, Schmitt CA, Gillespie KM, Chung HD. Blood pressure regulation in Alzheimer's disease. J Auton Nerv Syst. 1994;48:65-71.
    OpenUrlCrossRefPubMed
  43. ↵
    Elmstahl S, Petersson M, Lilja B, Samuelsson SM, Rosen I, Bjuno L. Autonomic cardiovascular responses to tilting in patients with Alzheimer's disease and in healthy elderly women. Age Ageing. 1992;21:301-307.
    OpenUrlAbstract/FREE Full Text
  44. ↵
    Vitiello B, Veith RC, Molchan SE, Martinez RA, Lawlor BA, Radcliffe J, Hill JL, Sunderland T. Autonomic dysfunction in patients with dementia of the Alzheimer-type. Biol Psychiatry. 1993;34:428-433.
    OpenUrlCrossRefPubMed
  45. ↵
    McGeer EG, McGeer PL, Kamo H, Tago H, Harrop R. Cortical metabolism, acetylcholinesterase staining and pathological changes in Alzheimer's disease. Can J Neurol Sci. 1986;13:511-516.
    OpenUrlPubMed
  46. ↵
    Hughes W. Atherosclerosis, Down's syndrome and Alzheimer's disease. Br Med J. 1977;2:702.
    OpenUrlFREE Full Text
  47. ↵
    Yla-Herttuala S, Luoma J, Nikkan T, Kivimski T. Down's syndrome and atherosclerosis. Atherosclerosis. 1989;76:269-272.
    OpenUrlCrossRefPubMed
  48. ↵
    Dickinson CJ. Control of blood pressure by the brain: vasomotor centre organization. In: Neurogenic Hypertension. London, UK: Chapman & Hall Medical; 1991:49-82.
  49. ↵
    Dewar D, McCulloch J. Abnormalities in non-cholinergic neurotransmitter systems in Alzheimer's disease. Dementia. 1994;5:159-183.
  50. ↵
    Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med. 1989;320:1446-1452.
    OpenUrlCrossRefPubMed
  51. ↵
    Neirinckx RD, Canning LR, Piper IM, Nowotnik DP, Pickett RD, Holmes RA, Volkert WA, Forster AM, Weisner PS, Marriott JA, Chaplin SB. Technetium-99m d,1-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med. 1987;28:191-202.
    OpenUrlAbstract/FREE Full Text
  52. ↵
    Stoppe G, Schutze R, Kogler A, Staedt J, Munz DL, Emrich D, Ruther E. Cerebrovascular reactivity to acetazolamide in (senile) dementia of Alzheimer's type. Dementia. 1995;6:73-82.
  53. ↵
    Obara K, Meyer JS, Mortel KF, Muramatsu K. Cognitive declines correlate with decreased cortical volume and perfusion in dementia of Alzheimer type. J Neurol Sci. 1994;127:96-102.
    OpenUrlCrossRefPubMed
  54. ↵
    Geaney DP, Soper N, Shepstone BJ, Cowen PJ. Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer's disease. Lancet. 1990;335:1484-1487.
    OpenUrlCrossRefPubMed
  55. ↵
    Montaldi D, Brooks DN, McColl JH, Wyper D, Patterson J, Barron E, McCulloch J. Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1990;53:33-38.
    OpenUrlAbstract/FREE Full Text
  56. ↵
    Ohnishi T, Hoshi H, Nagamachi S, Jinnouchi S, Flores LG, Futami S, Watanabe K. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med. 1995;36:1163-1169.
    OpenUrlAbstract/FREE Full Text
  57. ↵
    Edvinsson L, Mackenzie ET, McCulloch J. Neurotransmitters: metabolic and vascular effects in vivo. In: Cerebral Blood Flow and Metabolism. New York, NY: Raven Press Publishers; 1993:159-180.
  58. Yanker BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 1989;245:417-420.
    OpenUrlAbstract/FREE Full Text
  59. ↵
    De la Torre JC, Mussivand T. Can disturbed brain microcirculation cause Alzheimer's disease? Neurol Res. 1993;15:146-153.
    OpenUrlPubMed
  60. ↵
    Englund E, Brun A, Gustafason L. A white-matter disease in dementia of Alzheimer's type: clinical and neuropathological correlates. Int J Ger Psychiatry. 1989;4:87-102.
  61. ↵
    Brun A, Gustafson L, Samuelsson SM, Ericsson C. Neuropathology of late life. Dementia. 1992;3:125-130.
  62. Fitch W, Ferguson GG, Sengupta D, Garibi J, Harper AM. Autoregulation of cerebral blood flow during controlled hypotension in baboons. J Neurol Neurosurg Psychiatry. 1976;39:1014-1022.
    OpenUrlAbstract/FREE Full Text
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Hypertension
October 1996, Volume 28, Issue 4
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Selected Abbreviations and Acronyms
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Low Blood Pressure in Down's Syndrome
    Rhona A. Morrison, Alice McGrath, Gillian Davidson, Jehoiada J. Brown, Gordon D. Murray and Anthony F. Lever
    Hypertension. 1996;28:569-575, originally published October 1, 1996
    https://doi.org/10.1161/01.HYP.28.4.569

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Low Blood Pressure in Down's Syndrome
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Low Blood Pressure in Down's Syndrome
    Rhona A. Morrison, Alice McGrath, Gillian Davidson, Jehoiada J. Brown, Gordon D. Murray and Anthony F. Lever
    Hypertension. 1996;28:569-575, originally published October 1, 1996
    https://doi.org/10.1161/01.HYP.28.4.569
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured